Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 193,780 | 119,150 | 101,200 | 28,270 | 5,650 |
| Cost of Goods | 111,770 | 70,200 | 77,440 | 19,340 | 750 |
| Gross Profit | 82,010 | 48,940 | 23,760 | 8,930 | 4,900 |
| Operating Expenses | 69,610 | 60,230 | 44,750 | 24,590 | 18,680 |
| Operating Income | 13,170 | -11,080 | -20,550 | -15,320 | -13,030 |
| Interest Expense | 6,780 | 3,460 | 520 | 550 | 0 |
| Other Income | 1,450 | 1,270 | 2,880 | 6,290 | 14,620 |
| Pre-tax Income | 7,840 | -13,270 | -18,190 | -9,580 | 1,590 |
| Income Tax | 6,880 | 4,240 | 4,420 | -3,060 | 0 |
| Net Income Continuous | -4,444 | -20,153 | -16,431 | -2,240 | 660 |
| Net Income | $-4,780 | $-20,150 | $-25,780 | $-2,240 | $660 |
| EPS Basic Total Ops | -5,998.80 | -28,194.40 | -25,794.80 | N/A | N/A |
| EPS Basic Continuous Ops | -5,555.00 | -28,790.00 | -27,385.00 | N/A | N/A |
| EPS Diluted Total Ops | -5,998.80 | -28,194.40 | -25,794.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -5,555.00 | -28,790.00 | -27,385.00 | N/A | N/A |
| EBITDA(a) | $20,620 | $-4,340 | $-18,130 | $-14,130 | $-12,060 |